WGU D236 OA V2 - (2026)
PATHOPHYSIOLOGY OA (3 SET
EXAMS) ACTUAL QUESTIONS &
LATEST MOCK PRACTICE SET
190 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
WGU D236 OA V2 - (2026) PATHOPHYSIOLOGY OA (3 SET EXAMS) ACTUAL QUESTIONS & STUDY GUIDE
(GUARANTEE PASS). It contains 190 carefully selected questions that reflect the most current exam content and
testing strategies. Each question is accompanied by a correct answer and a detailed rationale that explains the
underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 190 Questions
Foundations - Application - WGU D236 OA V2 2026 Pathophysiology OA 3 Exams Actual & Study Guide
Guarantee PASS Pathophysiology Undergraduate YEAR 3 / Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Chronic 1-48 Likely, Explains, Mechanism, Condition, Serum
Explains 49-96 Chronic, Mechanism, Disease, Pathophysiological, Develops
Disease 97-144 Chronic, Explains, Mechanism, Kidney, Serum
Mechanism 145-190 Chronic, Likely, Develops, Disease, Explains
TOTAL 190 All questions include answers and detailed rationales
,Section A - Chronic
Q1.
In the pathogenesis of type 2 diabetes mellitus, which molecular mechanism best explains
the transition from compensatory hyperinsulinemia to overt -cell failure?
A. Progressive loss of glucokinase B. Amyloid deposition in pancreatic islets
sensitivity in -cells due to chronic leading to -cell apoptosis and reduced
hyperglycemia functional mass
C. Downregulation of insulin receptors on D. Autoimmune destruction of -cells
skeletal muscle causing post-receptor mediated by cytotoxic T lymphocytes
signaling blockade
Correct: B - Amyloid deposition in pancreatic islets leading to -cell apoptosis and reduced
functional mass
Rationale:Chronic hyperglycemia and insulin resistance lead to increased islet amyloid
polypeptide (IAPP) secretion, which aggregates as amyloid, inducing -cell apoptosis and
reducing -cell mass, a hallmark of type 2 diabetes progression. Glucokinase mutations are
rare and cause maturity-onset diabetes of the young, not the typical progression. Insulin
receptor downregulation contributes to resistance but is not the primary cause of -cell failure.
Autoimmune destruction is characteristic of type 1 diabetes.
Q2.
In the setting of prolonged systemic hypoxemia, which compensatory mechanism is most
directly responsible for the initial increase in cerebral blood flow?
A. Increased arterial partial pressure of B. Hypoxia-induced release of nitric oxide
carbon dioxide leading to cerebral from perivascular nerves
vasodilation
C. Stimulation of central chemoreceptors D. Increased production of adenosine and
causing sympathetic-mediated lactate in brain tissue causing vasodilation
vasoconstriction
Correct: D - Increased production of adenosine and lactate in brain tissue causing
vasodilation
Rationale:During hypoxemia, brain tissue produces vasodilatory metabolites, especially
adenosine and lactate, which act directly on vascular smooth muscle to increase cerebral
blood flow. Increased PaCO2 also vasodilates, but in systemic hypoxemia, PaCO2 may be
low due to hyperventilation. Nitric oxide is released, but it is not the primary initial mediator.
Sympathetic activation would cause vasoconstriction, not increased flow.
Page 3
, Section A - Chronic
Q3.
A patient with chronic kidney disease has a serum calcium of 7.2 mg/dL, phosphate of 5.8
mg/dL, and elevated intact PTH. Which pathophysiological mechanism is most likely
driving the hyperparathyroidism?
A. Decreased renal production of calcitriol B. Phosphate retention directly stimulating
leading to impaired intestinal calcium parathyroid chief cell proliferation
absorption
C. Skeletal resistance to PTH action causing D. Reduced degradation of PTH by the
compensatory hypersecretion diseased kidneys increasing its half-life
Correct: A - Decreased renal production of calcitriol leading to impaired intestinal calcium
absorption
Rationale:In chronic kidney disease, decreased renal 1±-hydroxylase activity reduces
calcitriol production, leading to decreased intestinal calcium absorption and hypocalcemia,
which stimulates PTH secretion. Phosphate retention contributes to hypocalcemia and may
stimulate PTH indirectly, but not directly. Skeletal resistance to PTH is a consequence, not the
cause. Reduced degradation of PTH occurs but is not the primary driver.
Q4.
A 45-year-old individual with a history of chronic alcoholism presents with jaundice,
coagulopathy, and ascites. Laboratory findings show elevated serum ammonia and a
prolonged prothrombin time. Which of the following contributes most directly to the
coagulopathy?
A. Impaired hepatic synthesis of vitamin B. Increased fibrinolysis due to decreased
K-dependent clotting factors plasminogen activator inhibitor-1
C. Thrombocytopenia secondary to D. Disseminated intravascular coagulation
hypersplenism from portal hypertension triggered by endotoxemia
Correct: A - Impaired hepatic synthesis of vitamin K-dependent clotting factors
Rationale:In liver failure, impaired hepatic synthesis of clotting factors, particularly vitamin
K-dependent factors (II, VII, IX, X), leads to prolonged prothrombin time. Hypersplenism
causes thrombocytopenia but does not prolong PT. Increased fibrinolysis is not a primary
cause. DIC is a complication but not the most direct cause of the PT prolongation in this
context.
Q5.
Which of the following mutations is most likely to result in a gain-of-function phenotype
that promotes oncogenesis?
A. Deletion of the p53 gene B. Amplification of the HER2/neu gene
Page 4
PATHOPHYSIOLOGY OA (3 SET
EXAMS) ACTUAL QUESTIONS &
LATEST MOCK PRACTICE SET
190 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
WGU D236 OA V2 - (2026) PATHOPHYSIOLOGY OA (3 SET EXAMS) ACTUAL QUESTIONS & STUDY GUIDE
(GUARANTEE PASS). It contains 190 carefully selected questions that reflect the most current exam content and
testing strategies. Each question is accompanied by a correct answer and a detailed rationale that explains the
underlying pathophysiology, pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 190 Questions
Foundations - Application - WGU D236 OA V2 2026 Pathophysiology OA 3 Exams Actual & Study Guide
Guarantee PASS Pathophysiology Undergraduate YEAR 3 / Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
Chronic 1-48 Likely, Explains, Mechanism, Condition, Serum
Explains 49-96 Chronic, Mechanism, Disease, Pathophysiological, Develops
Disease 97-144 Chronic, Explains, Mechanism, Kidney, Serum
Mechanism 145-190 Chronic, Likely, Develops, Disease, Explains
TOTAL 190 All questions include answers and detailed rationales
,Section A - Chronic
Q1.
In the pathogenesis of type 2 diabetes mellitus, which molecular mechanism best explains
the transition from compensatory hyperinsulinemia to overt -cell failure?
A. Progressive loss of glucokinase B. Amyloid deposition in pancreatic islets
sensitivity in -cells due to chronic leading to -cell apoptosis and reduced
hyperglycemia functional mass
C. Downregulation of insulin receptors on D. Autoimmune destruction of -cells
skeletal muscle causing post-receptor mediated by cytotoxic T lymphocytes
signaling blockade
Correct: B - Amyloid deposition in pancreatic islets leading to -cell apoptosis and reduced
functional mass
Rationale:Chronic hyperglycemia and insulin resistance lead to increased islet amyloid
polypeptide (IAPP) secretion, which aggregates as amyloid, inducing -cell apoptosis and
reducing -cell mass, a hallmark of type 2 diabetes progression. Glucokinase mutations are
rare and cause maturity-onset diabetes of the young, not the typical progression. Insulin
receptor downregulation contributes to resistance but is not the primary cause of -cell failure.
Autoimmune destruction is characteristic of type 1 diabetes.
Q2.
In the setting of prolonged systemic hypoxemia, which compensatory mechanism is most
directly responsible for the initial increase in cerebral blood flow?
A. Increased arterial partial pressure of B. Hypoxia-induced release of nitric oxide
carbon dioxide leading to cerebral from perivascular nerves
vasodilation
C. Stimulation of central chemoreceptors D. Increased production of adenosine and
causing sympathetic-mediated lactate in brain tissue causing vasodilation
vasoconstriction
Correct: D - Increased production of adenosine and lactate in brain tissue causing
vasodilation
Rationale:During hypoxemia, brain tissue produces vasodilatory metabolites, especially
adenosine and lactate, which act directly on vascular smooth muscle to increase cerebral
blood flow. Increased PaCO2 also vasodilates, but in systemic hypoxemia, PaCO2 may be
low due to hyperventilation. Nitric oxide is released, but it is not the primary initial mediator.
Sympathetic activation would cause vasoconstriction, not increased flow.
Page 3
, Section A - Chronic
Q3.
A patient with chronic kidney disease has a serum calcium of 7.2 mg/dL, phosphate of 5.8
mg/dL, and elevated intact PTH. Which pathophysiological mechanism is most likely
driving the hyperparathyroidism?
A. Decreased renal production of calcitriol B. Phosphate retention directly stimulating
leading to impaired intestinal calcium parathyroid chief cell proliferation
absorption
C. Skeletal resistance to PTH action causing D. Reduced degradation of PTH by the
compensatory hypersecretion diseased kidneys increasing its half-life
Correct: A - Decreased renal production of calcitriol leading to impaired intestinal calcium
absorption
Rationale:In chronic kidney disease, decreased renal 1±-hydroxylase activity reduces
calcitriol production, leading to decreased intestinal calcium absorption and hypocalcemia,
which stimulates PTH secretion. Phosphate retention contributes to hypocalcemia and may
stimulate PTH indirectly, but not directly. Skeletal resistance to PTH is a consequence, not the
cause. Reduced degradation of PTH occurs but is not the primary driver.
Q4.
A 45-year-old individual with a history of chronic alcoholism presents with jaundice,
coagulopathy, and ascites. Laboratory findings show elevated serum ammonia and a
prolonged prothrombin time. Which of the following contributes most directly to the
coagulopathy?
A. Impaired hepatic synthesis of vitamin B. Increased fibrinolysis due to decreased
K-dependent clotting factors plasminogen activator inhibitor-1
C. Thrombocytopenia secondary to D. Disseminated intravascular coagulation
hypersplenism from portal hypertension triggered by endotoxemia
Correct: A - Impaired hepatic synthesis of vitamin K-dependent clotting factors
Rationale:In liver failure, impaired hepatic synthesis of clotting factors, particularly vitamin
K-dependent factors (II, VII, IX, X), leads to prolonged prothrombin time. Hypersplenism
causes thrombocytopenia but does not prolong PT. Increased fibrinolysis is not a primary
cause. DIC is a complication but not the most direct cause of the PT prolongation in this
context.
Q5.
Which of the following mutations is most likely to result in a gain-of-function phenotype
that promotes oncogenesis?
A. Deletion of the p53 gene B. Amplification of the HER2/neu gene
Page 4
